Top of this page
Skip navigation, go straight to the content
Investor News
- UCB delivers solid growth from its new medicines Cimzia, Vimpat and Neupro 02-Aug-2010
- UCB to out-license six established products to Actient Pharmaceuticals, LLC 30-Jul-2010
- E Keppra (levetiracetam) receives regulatory approval in Japan 23-Jul-2010
- UCB strengthens ICT department to foster its transformation into a global patient centric biopharma leader 19-Jul-2010
- UCB strengthens strategic alliance with WILEX 09-Jun-2010
- UCB's Roch Doliveux joins Board of the Innovative Medicines Initiative 17-May-2010
- UCB: Delivering for patients through innovation 28-Apr-2010
